FDA gives preliminary approval to new insomnia drug

03/1/2004 | NYTimes.com

The FDA's "approvable" letter to Sepracor for its Estorra drug allows the Massachusetts drug company to bypass additional clinical or pre-clinical trials for the drug's final approval. The company said it hopes to begin marketing the drug as early as the middle of the year.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI